首頁
Diamond Pharma Services

7月 2026Diamond Pharma Services的市場佔有率分析

Learn why establishing a mature Data Integrity culture is important and how to go about creating and maintaining a program for your organization.

行業: N/A

域名diamondpharmaservices.com

成立年份2005

僱員51 - 200

年度營收$10M - $15M

Diamond Pharma Services

Diamond Pharma Services（包含公司地區）

diamondpharmaservices.com

查看更多網站流量與參與度資訊

Diamond Pharma Services截至 7月 2026 的總收入為 10M - 15M

Diamond Pharma Services 熱門網域產生的總收入

Diamond Pharma Services 熱門網域 3 年內的總收入

Diamond Pharma Services 熱門網域的總收入

diamondpharmaservices.com10M - 15M

透過銷售情報查看更多內容

Diamond Pharma Services的熱門網域總造訪量

了解Diamond Pharma Services市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

無可顯示數據

Diamond Pharma Services的熱門網域平均造訪時長

分析Diamond Pharma Services參與度指標。

過去 3 個月平均造訪時長

無可顯示數據

Diamond Pharma Services的熱門網域平均頁面瀏覽量

了解Diamond Pharma Services如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

無可顯示數據

Diamond Pharma Services按網域劃分的熱門競爭對手

7月 2026的熱門類似網站，依相似度排名

diamondpharma.com公司名Diamond Pharma僱員501 - 1000總部敘利亞, Damascus年度營收$15M - $25M訪問總量463N/A

使用的熱門技術Diamond Pharma Services

这些是Diamond Pharma Services顶级域名使用的行业网站技术

付款與貨幣 (21)

PayPal

付費廣告 (4)

LinkedIn Advertiser

音訊視訊媒體 (2)

YouTube

多語言 (2)

Multilingual Support

更多技術

11

檢視所有

新聞與訊號來自Diamond Pharma Services

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞ProPharma Group acquired Diamondpharmaservices on Mar 1st '21.ProPharma Group, a portfolio company of Odyssey Investment Partners, announces the acquisition of Diamond Pharma Services.

新聞Diamondpharmaservices expands offices in Europe.Through the acquisition, Diamond expects to expand its presence in Europe, as well as enhance its senior-level expertise within the company’s pharmacovigilance team.

新聞Diamondpharmaservices received award Futures and Support Award at The Organisation for Professionals in Regulatory Affairs (TOPRA) Awards on Nov 2nd '18.Diamond Pharma Services Ltd (“Diamond”), a leading technical services and regulatory affairs consulting group, providing expert support and advice to pharmaceutical and biotechnology companies, has received both the Futures and Support Award at The Organisation for Professionals in Regulatory Affairs (TOPRA) Awards.